Detect GPCRs in research, drug discovery, diagnostics, and therapeutic development
What's inside the book?
Introduction to GPCR & Membrane Protein Antibodies
Overview of Conigen’s antibody discovery platform and applications in research, diagnostics, and therapeutics.
AI-Enabled Precision Antibody Discovery Platform
Immunogen engineering, immune-focusing strategies, and methods for breaking immune tolerance.
Integrated Workflow & Technology Platform
End-to-end process from target analysis and immunogen design to antibody screening and validation.
Why Extracellular Domain (ECD) GPCR Antibodies Matter
Importance of live-cell staining, receptor specificity, and native-state GPCR detection.
GPCR Monoclonal Antibody Portfolio
Overview of GPCR targets across cardiovascular, metabolic, immunology, neurology, oncology, and psychiatry applications.
Spotlight Antibodies & Case Studies
Featured antibodies including DRD2, PAR1, GPR52, GPR75, GLP1R, GIPR, MAS1, APLNR, CALRL, LGR4, FZD10, ADGRE2, GPR19, and P2RY13.
Other Membrane Protein Antibody Platforms
CD3-epsilon/delta, IFNαR1/R2 heterodimer, and CFTR extracellular loop antibodies.
Validation & Performance Data
ELISA, SPR affinity, and live-cell flow cytometry characterization examples.